Literature DB >> 2463773

Vascular development in chick embryos: a possible role for adenosine.

T H Adair1, J P Montani, D M Strick, A C Guyton.   

Abstract

We studied the possible role of adenosine in the development of the vasculature using 217 chick embryos. Adenosine (2-32 mumol/day), inosine (16 mumol/day), dipyridamole (0.04-0.4 mumol/day), or aminophylline (400 and 800 micrograms/day) were administered twice each day into the air space on days 11-14. Control embryos received Ringer solution. Whole body vascularity was estimated on day 15 as the whole body structural vascular resistance (SVR), i.e., the hydraulic resistance of the maximally dilated vasculature. Adenosine decreased the SVR in a dose-related manner at the lower dosage amounts but caused a maximum decrease in SVR at the higher dosage amounts averaging 30% below the Ringer control values. Equimolar amounts of adenosine and inosine decreased the SVR by the same extent. Dipyridamole, which potentiates the biological effects of endogenous adenosine, also decreased the SVR in a dose-related manner to values averaging approximately 30% below control. When the effects of endogenous adenosine were blocked by aminophylline, the SVR increased in a dose-related manner to approximately 100% above control at the highest dosage amount. These results suggest that adenosine could have a physiological role in growth regulation of the vascular system in the chick embryo.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2463773     DOI: 10.1152/ajpheart.1989.256.1.H240

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

Review 1.  Adenosine receptors in wound healing, fibrosis and angiogenesis.

Authors:  Igor Feoktistov; Italo Biaggioni; Bruce N Cronstein
Journal:  Handb Exp Pharmacol       Date:  2009

Review 2.  Purinergic signaling in embryonic and stem cell development.

Authors:  Geoffrey Burnstock; Henning Ulrich
Journal:  Cell Mol Life Sci       Date:  2011-01-08       Impact factor: 9.261

3.  Variants of the adenosine A(2A) receptor gene are protective against proliferative diabetic retinopathy in patients with type 1 diabetes.

Authors:  Bashira A Charles; Yvette P Conley; Guanjie Chen; Rachel G Miller; Janice S Dorman; Michael B Gorin; Robert E Ferrell; Susan M Sereika; Charles N Rotimi; Trevor J Orchard
Journal:  Ophthalmic Res       Date:  2010-11-19       Impact factor: 2.892

Review 4.  Purinergic signalling during development and ageing.

Authors:  Geoffrey Burnstock; Nicholas Dale
Journal:  Purinergic Signal       Date:  2015-05-20       Impact factor: 3.765

Review 5.  Purines as potential morphogens during embryonic development.

Authors:  Karine Massé; Nicholas Dale
Journal:  Purinergic Signal       Date:  2012-01-25       Impact factor: 3.765

6.  Adenosine infusion increases plasma levels of VEGF in humans.

Authors:  Thomas H Adair; Reid Cotten; Jian-Wei Gu; Janelle S Pryor; Kenneth R Bennett; Michael R McMullan; Preston McDonnell; Jean-Pierre Montani
Journal:  BMC Physiol       Date:  2005-06-20

7.  Adenosine receptor-mediated adhesion of endothelial progenitors to cardiac microvascular endothelial cells.

Authors:  Sergey Ryzhov; Nataliya V Solenkova; Anna E Goldstein; Mathias Lamparter; Todd Fleenor; Pampee P Young; James P Greelish; John G Byrne; Douglas E Vaughan; Italo Biaggioni; Antonis K Hatzopoulos; Igor Feoktistov
Journal:  Circ Res       Date:  2007-11-21       Impact factor: 17.367

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.